Skip to main content

Table 4 Evaluation between the convertors and non-convertors

From: Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia

 

two-years follow up

three-years follow up

MCI-nc

(n = 70, 90%)

MCI-c

(n = 8,10%)

OR

(95% CI)

P

MCI-nc

(n = 62, 79%)

MCI-c

(n = 16, 21%)

OR

(95% CI)

P

SS-16

  < 8

18 (26%)

6 (75%)

0.12 (0.02–0.6)

0.012

27 (44%)

14 (88%)

0.1 (0.02–0.5)

0.006

  ≥ 8

52 (74%)

2 (25%)

35 (56%)

2 (12%)

1–42, pg/ml

  < 14.02

43 (61%)

7 (88%)

11.1 (1.3–95.7)

0.028

41 (66%)

3 (19%)

8.5 (2.2–33)

0.002

  ≥ 14.02

27 (39%)

1 (12%)

21 (34%)

13 (81%)

ApoE ε4 carrier

 (+)

12 (17%)

2 (25%)

1.6 (0.29–9.0)

0.590

10 (16%)

4 (25%)

1.7 (0.5–6.5)

0.415

 (−)

58 (83%)

6 (75%)

  

52 (84%)

12 (75%)

  
  1. All results were adjusted for age and sex
  2. Abbreviations: SS-16 the 16-item odor identification test from Sniffin Sticks